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BACKGROUND 
 
Despite Aboriginal and Torres Strait 
islander people having increased risk 
factors for OSA (diabetes, obesity) and  
 
 
 
 
 
 
 
 
 
 
 
AIMS/OBJECTIVES 
 
The aim of this study was to compare 
the use of sleep diagnostic tests, the 
risks, and cofactors, and outcomes of 
the care of Indigenous and non-
indigenous Australian adults in regional 
and remote Australia in whom sleep 
related breathing disorders have been 
diagnosed.  
METHODS 
 
A retrospective cohort study of 200 
sequential subjects: 100 Aboriginal 
and/or Torres Strait Islander people and 
100 non-Indigenous Australians in 
northern Queensland and Central 
Australia. Subjects were eighteen years 
or older with a diagnosed sleep 
disorder (AHI > 15). Retrospective data 
collected from patients’ medical records 
included: demographics; co-
morbidities; BMI; fatigue score; referral 
source and management details for 12 
months following diagnosis. Follow up 
included the number of reviews booked 
and number of reviews attended. 
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RESULTS 
 
 
 
 
 
 
 
DISCUSSION 
Accessing sleep services is a 
significant issue for Indigenous and 
non-Indigenous Australians living in 
regional and remote communities. 
Aboriginal and Torres Strait Islanders 
suffering from sleep disorders are 
more likely to be; younger, female, 
obese and have a history of chronic 
disease. 
Access to sleep services in these 
regional and remote communities 
is poorer than that seen in 
Australia overall (see Table below), 
particularly for Aboriginal and 
Torres Strait Islander people. 
Reasons for this may include: 
 
1. Population at much lower risk 
Unlikely, especially in Indigenous Australians 
with greater obesity and co-morbidities. 
2. Accessing other diagnostic services 
Likely for non-Indigenous Australians but 
unlikely for Indigenous Australians who rarely 
access private healthcare. 
3. Differing referral patterns 
Only people perceived likely to be able to 
attend, afford and/or comply with treatment 
are referred for diagnostic sleep studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
There is a poorer uptake of treatment 
following sleep studies in Indigenous 
Australians. This may occur because: 
1. more remote and more limited 
access to follow-up services 
2. cost implications (replacement of 
machines, masks etc).  
 
CONCLUSION 
Appropriate and more accessible 
diagnostic and treatment sleep 
services are required in regional and 
remote Australia. Further research is 
required to validate appropriate 
screening tools and pathways of care 
especially for Aboriginal and Torres 
Strait Islander peoples. 
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Aboriginal and Torres Strait Islander
Non-Indigenous Australian
high levels of comorbid associated 
conditions (chronic non-communicable 
diseases) there are currently no 
published data relating to the nature of 
sleep-related breathing disorders 
affecting Indigenous adults. Although 
there is considerable information from 
metropolitan services regarding 
diagnostic and management pathways 
for OSA, there is less information 
regarding care for Australians living in 
regional and remote Australia and 
particularly for Indigenous Australians.  
Machines can be ‘fragile’ 
Aboriginal &/or Torres 
Strait Islander 
Non-Indigenous 
Australian 
Time between referral and 
diagnostic study (Median weeks, 
IQR) 
27.5 (13.0-62.2) 24.9 (11.7-47.6) 
Diagnosis (%, 95% CI) 
Obstructive sleep apnoea 98 (93-100) 97 (91-99) 
Central sleep apnoea 0 2 (0 - 7) 
Cheyne Stokes respiration 2 (0 - 7) 2 (0 - 7) 
Apnoea Hypopnoea Index (AHI)  
(Median events/hour, IQR) 
34.5 (19 - 77) 29.4 (15 - 57) 
Treatment recommendation (%, 95% CI) 
CPAP 69 (59 - 78) 67 (56 - 76) 
ENT referral 3 (1 - 9) 7 (0 - 6) 
Lifestyle modification 42 (32 - 52) 14 (8 - 23)* 
Bilevel ventilation 3 (1 - 9) 1 (0 - 6) 
Follow-up for 12 months following diagnostic study 
Failed to attend any reviews 
(%, 95% CI) 
38 (27 - 49) 19 (11 - 30)* 
Time to first review following 
diagnostic study (Median weeks, 
IQR) 
22.3 (9.9 - 33.3) 20.6 (12.4 - 32.1) 
Aboriginal &/or Torres 
Strait Islander 
Non-Indigenous 
Australian 
Number 100 100 
Age (mean,SD)  47.3 (12.6) 50.7 (12.7) 
Ethnicity n (%) 
Aboriginal 86 (43%) - 
Torres Strait Islander 12 (6%) - 
Aboriginal & Torres Strait Is. 2 (1%) - 
Gender (% female,95% CI) 48.0 (38 - 57) 26.0 (18 - 36)* 
Location (% very remote,95% CI) 37.9 (28 - 48) 8.4 (4 - 16)* 
Co-morbidities (%,95% CI) 
Chronic lung disease 34.0 (25 - 44) 22.2 (15 - 32) 
Heart disease 28.0 (20 - 38) 13.1 (7- 21)* 
Chronic kidney disease 14.6 (8 - 23) 2.50(0 - 9)* 
Peptic ulcer disease 19.8 (12 - 30) 22.80 (14 - 34) 
Diabetes 51.0 (41 – 61) 24.20 (16 - 34)* 
Hypertension 72.0 (62 - 81) 39.40 (30 - 50)* 
Upper Airway Obstruction 9.00 (4 -17) 26.30 (17- 38)* 
BMI (mean, SD) 40.0 (10.7) 34.9 (10.2)* 
(%, 95% CI) Underweight <20 0 0 
Normal 20-25 1.2 (0. 7) 7.1 (3 -15) 
Overweight 26-30 4.9 (1 - 12) 16.7 (9 - 26) 
Obese >30 93.8 (86 - 98) 76.2 (66 - 85) 
ESS (Median,IQR) 10 (7, 15) 10 (6, 15) 
ESS assessed (%,95% CI) 92.0 (85 - 97) 97.0 (92 - 99) 
ESS – Epworth Sleepiness Score, *p<0.05 
*p<0.05 
Subject Characteristics 
Indication for diagnostic sleep study 
Diagnosis and Follow Up 
www.bakeridi.edu.au cindy.woods@jcu.edu.au www.jcu.edu.au 
Overall Australian rate (2012) 575/100,000/pa 
FNQ – Far North Queensland, CA – Central Australia 
Aboriginal and 
Torres Strait 
Islander 
Non-
Indigenous 
Australian 
All p value 
Number of sleep studies/100,000/yr (95% CI) 
FNQ 44 (32 - 59) 30 (20 - 43) 32 (22 - 45) 0.130 
CA 104 (85 - 126) 203 (176 - 233) 163 (139 -190) <0.001 
All 62  (47 - 79) 50 (37 - 66) 52 (39 - 68) 0.298 
P Value <0.001 <0.001 <0.001 
Number of positive sleep studies/100,000/yr (95% CI) 
FNQ 30 (20-43) 16 (9 -26) 18 (11 - 28) 0.054 
CA 73 (57-92) 121 (100 - 144) 101 (82 - 123) <0.001 
All 43 (31-58) 28 (19 - 40) 31 (21 - 44) 0.095 
P Value <0.001 <0.001 <0.001 
Diagnostic study rates 
